nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Ifosfamide—testicular cancer	0.15	0.34	CbGbCtD
Tramadol—CYP2B6—Cisplatin—testicular cancer	0.0727	0.165	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—testicular cancer	0.0487	0.111	CbGbCtD
Tramadol—CYP3A4—Ifosfamide—testicular cancer	0.0459	0.104	CbGbCtD
Tramadol—CYP2D6—Vinblastine—testicular cancer	0.0383	0.0871	CbGbCtD
Tramadol—CYP3A4—Vinblastine—testicular cancer	0.0244	0.0554	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—testicular cancer	0.0235	0.0535	CbGbCtD
Tramadol—CYP3A4—Etoposide—testicular cancer	0.022	0.0499	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—testicular cancer	0.015	0.034	CbGbCtD
Tramadol—Hepatitis—Epirubicin—testicular cancer	0.000241	0.000431	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—testicular cancer	0.000241	0.00043	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—testicular cancer	0.00024	0.000429	CcSEcCtD
Tramadol—Hypoaesthesia—Epirubicin—testicular cancer	0.00024	0.000429	CcSEcCtD
Tramadol—Asthenia—Cisplatin—testicular cancer	0.000239	0.000428	CcSEcCtD
Tramadol—Pharyngitis—Epirubicin—testicular cancer	0.000239	0.000427	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—testicular cancer	0.000239	0.000427	CcSEcCtD
Tramadol—Sweating—Doxorubicin—testicular cancer	0.000238	0.000426	CcSEcCtD
Tramadol—Urinary tract disorder—Epirubicin—testicular cancer	0.000238	0.000425	CcSEcCtD
Tramadol—Oedema peripheral—Epirubicin—testicular cancer	0.000238	0.000424	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—testicular cancer	0.000237	0.000423	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—testicular cancer	0.000237	0.000423	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—testicular cancer	0.000236	0.000422	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000235	0.00042	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—testicular cancer	0.000234	0.000419	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—testicular cancer	0.000234	0.000418	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—testicular cancer	0.000233	0.000416	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—testicular cancer	0.000233	0.000416	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—testicular cancer	0.000232	0.000415	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—testicular cancer	0.000232	0.000415	CcSEcCtD
Tramadol—Chills—Methotrexate—testicular cancer	0.000231	0.000413	CcSEcCtD
Tramadol—Nausea—Ifosfamide—testicular cancer	0.00023	0.000411	CcSEcCtD
Tramadol—Diarrhoea—Cisplatin—testicular cancer	0.000228	0.000408	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—testicular cancer	0.000228	0.000407	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—testicular cancer	0.000227	0.000406	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—testicular cancer	0.000226	0.000403	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—testicular cancer	0.000225	0.000403	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—testicular cancer	0.000225	0.000402	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—testicular cancer	0.000225	0.000402	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—testicular cancer	0.000224	0.000401	CcSEcCtD
Tramadol—Erythema—Methotrexate—testicular cancer	0.000224	0.000401	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—testicular cancer	0.000224	0.000401	CcSEcCtD
Tramadol—Flushing—Epirubicin—testicular cancer	0.000224	0.0004	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—testicular cancer	0.000224	0.0004	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—testicular cancer	0.000224	0.0004	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—testicular cancer	0.000223	0.000399	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—testicular cancer	0.000223	0.000399	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—testicular cancer	0.000222	0.000397	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—testicular cancer	0.000221	0.000396	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—testicular cancer	0.00022	0.000394	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—testicular cancer	0.00022	0.000393	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—testicular cancer	0.00022	0.000392	CcSEcCtD
Tramadol—Asthenia—Etoposide—testicular cancer	0.000219	0.000392	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000219	0.000392	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—testicular cancer	0.000219	0.000391	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—testicular cancer	0.000219	0.000391	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—testicular cancer	0.000218	0.000389	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—testicular cancer	0.000217	0.000388	CcSEcCtD
Tramadol—Back pain—Methotrexate—testicular cancer	0.000217	0.000388	CcSEcCtD
Tramadol—Chills—Epirubicin—testicular cancer	0.000216	0.000386	CcSEcCtD
Tramadol—Pruritus—Etoposide—testicular cancer	0.000216	0.000386	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—testicular cancer	0.000215	0.000385	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—testicular cancer	0.000215	0.000384	CcSEcCtD
Tramadol—Vomiting—Cisplatin—testicular cancer	0.000212	0.000379	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—testicular cancer	0.000211	0.000378	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—testicular cancer	0.000211	0.000377	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—testicular cancer	0.000211	0.000377	CcSEcCtD
Tramadol—Rash—Cisplatin—testicular cancer	0.00021	0.000376	CcSEcCtD
Tramadol—Dermatitis—Cisplatin—testicular cancer	0.00021	0.000375	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—testicular cancer	0.00021	0.000375	CcSEcCtD
Tramadol—Erythema—Epirubicin—testicular cancer	0.00021	0.000375	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—testicular cancer	0.000209	0.000373	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—testicular cancer	0.000209	0.000372	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—testicular cancer	0.000208	0.000372	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—testicular cancer	0.000208	0.000372	CcSEcCtD
Tramadol—Anaemia—Methotrexate—testicular cancer	0.000207	0.00037	CcSEcCtD
Tramadol—Flushing—Doxorubicin—testicular cancer	0.000207	0.00037	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—testicular cancer	0.000207	0.00037	CcSEcCtD
Tramadol—Flatulence—Epirubicin—testicular cancer	0.000207	0.000369	CcSEcCtD
Tramadol—Tension—Epirubicin—testicular cancer	0.000206	0.000368	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—testicular cancer	0.000206	0.000367	CcSEcCtD
Tramadol—Nervousness—Epirubicin—testicular cancer	0.000204	0.000364	CcSEcCtD
Tramadol—Back pain—Epirubicin—testicular cancer	0.000203	0.000363	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—testicular cancer	0.000202	0.000362	CcSEcCtD
Tramadol—Malaise—Methotrexate—testicular cancer	0.000202	0.000361	CcSEcCtD
Tramadol—Dizziness—Etoposide—testicular cancer	0.000202	0.000361	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—testicular cancer	0.000202	0.00036	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—testicular cancer	0.000202	0.00036	CcSEcCtD
Tramadol—Vertigo—Methotrexate—testicular cancer	0.000202	0.00036	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000201	0.000359	CcSEcCtD
Tramadol—Chills—Doxorubicin—testicular cancer	0.0002	0.000358	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—testicular cancer	0.000199	0.000356	CcSEcCtD
Tramadol—Nausea—Cisplatin—testicular cancer	0.000198	0.000354	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—testicular cancer	0.000198	0.000353	CcSEcCtD
Tramadol—Cough—Methotrexate—testicular cancer	0.000196	0.00035	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—testicular cancer	0.000195	0.000349	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—testicular cancer	0.000195	0.000348	CcSEcCtD
Tramadol—Convulsion—Methotrexate—testicular cancer	0.000194	0.000347	CcSEcCtD
Tramadol—Vomiting—Etoposide—testicular cancer	0.000194	0.000347	CcSEcCtD
Tramadol—Erythema—Doxorubicin—testicular cancer	0.000194	0.000347	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—testicular cancer	0.000194	0.000347	CcSEcCtD
Tramadol—Anaemia—Epirubicin—testicular cancer	0.000194	0.000347	CcSEcCtD
Tramadol—Agitation—Epirubicin—testicular cancer	0.000193	0.000345	CcSEcCtD
Tramadol—Rash—Etoposide—testicular cancer	0.000193	0.000344	CcSEcCtD
Tramadol—Dermatitis—Etoposide—testicular cancer	0.000193	0.000344	CcSEcCtD
Tramadol—Headache—Etoposide—testicular cancer	0.000191	0.000342	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—testicular cancer	0.000191	0.000342	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—testicular cancer	0.000191	0.000341	CcSEcCtD
Tramadol—Myalgia—Methotrexate—testicular cancer	0.000191	0.000341	CcSEcCtD
Tramadol—Chest pain—Methotrexate—testicular cancer	0.000191	0.000341	CcSEcCtD
Tramadol—Tension—Doxorubicin—testicular cancer	0.000191	0.00034	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—testicular cancer	0.00019	0.00034	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00019	0.000339	CcSEcCtD
Tramadol—Malaise—Epirubicin—testicular cancer	0.000189	0.000338	CcSEcCtD
Tramadol—Discomfort—Methotrexate—testicular cancer	0.000189	0.000337	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—testicular cancer	0.000189	0.000337	CcSEcCtD
Tramadol—Vertigo—Epirubicin—testicular cancer	0.000189	0.000337	CcSEcCtD
Tramadol—Syncope—Epirubicin—testicular cancer	0.000188	0.000336	CcSEcCtD
Tramadol—Back pain—Doxorubicin—testicular cancer	0.000188	0.000336	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—testicular cancer	0.000187	0.000334	CcSEcCtD
Tramadol—Palpitations—Epirubicin—testicular cancer	0.000186	0.000331	CcSEcCtD
Tramadol—Confusional state—Methotrexate—testicular cancer	0.000185	0.00033	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—testicular cancer	0.000185	0.00033	CcSEcCtD
Tramadol—Cough—Epirubicin—testicular cancer	0.000183	0.000327	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—testicular cancer	0.000183	0.000327	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—testicular cancer	0.000183	0.000327	CcSEcCtD
Tramadol—Convulsion—Epirubicin—testicular cancer	0.000182	0.000325	CcSEcCtD
Tramadol—Infection—Methotrexate—testicular cancer	0.000182	0.000325	CcSEcCtD
Tramadol—Nausea—Etoposide—testicular cancer	0.000182	0.000324	CcSEcCtD
Tramadol—Hypertension—Epirubicin—testicular cancer	0.000181	0.000324	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—testicular cancer	0.00018	0.000322	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—testicular cancer	0.00018	0.000321	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—testicular cancer	0.00018	0.000321	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—testicular cancer	0.000179	0.00032	CcSEcCtD
Tramadol—Chest pain—Epirubicin—testicular cancer	0.000179	0.000319	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—testicular cancer	0.000179	0.000319	CcSEcCtD
Tramadol—Myalgia—Epirubicin—testicular cancer	0.000179	0.000319	CcSEcCtD
Tramadol—Agitation—Doxorubicin—testicular cancer	0.000179	0.000319	CcSEcCtD
Tramadol—Anxiety—Epirubicin—testicular cancer	0.000178	0.000318	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—testicular cancer	0.000178	0.000318	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000178	0.000317	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—testicular cancer	0.000177	0.000316	CcSEcCtD
Tramadol—Discomfort—Epirubicin—testicular cancer	0.000177	0.000315	CcSEcCtD
Tramadol—Malaise—Doxorubicin—testicular cancer	0.000175	0.000313	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—testicular cancer	0.000175	0.000312	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—testicular cancer	0.000175	0.000312	CcSEcCtD
Tramadol—Anorexia—Methotrexate—testicular cancer	0.000175	0.000312	CcSEcCtD
Tramadol—Syncope—Doxorubicin—testicular cancer	0.000174	0.000311	CcSEcCtD
Tramadol—Confusional state—Epirubicin—testicular cancer	0.000173	0.000309	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—testicular cancer	0.000172	0.000307	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—testicular cancer	0.000171	0.000306	CcSEcCtD
Tramadol—Hypotension—Methotrexate—testicular cancer	0.000171	0.000306	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—testicular cancer	0.000171	0.000305	CcSEcCtD
Tramadol—Infection—Epirubicin—testicular cancer	0.00017	0.000304	CcSEcCtD
Tramadol—Cough—Doxorubicin—testicular cancer	0.00017	0.000303	CcSEcCtD
Tramadol—Shock—Epirubicin—testicular cancer	0.000169	0.000301	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—testicular cancer	0.000168	0.000301	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—testicular cancer	0.000168	0.0003	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—testicular cancer	0.000168	0.0003	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—testicular cancer	0.000168	0.0003	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—testicular cancer	0.000167	0.000299	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000167	0.000298	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—testicular cancer	0.000166	0.000297	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—testicular cancer	0.000166	0.000296	CcSEcCtD
Tramadol—Insomnia—Methotrexate—testicular cancer	0.000166	0.000296	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—testicular cancer	0.000165	0.000295	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—testicular cancer	0.000165	0.000295	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—testicular cancer	0.000165	0.000295	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—testicular cancer	0.000165	0.000294	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—testicular cancer	0.000164	0.000294	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000164	0.000293	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—testicular cancer	0.000163	0.000292	CcSEcCtD
Tramadol—Anorexia—Epirubicin—testicular cancer	0.000163	0.000292	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—testicular cancer	0.000163	0.000292	CcSEcCtD
Tramadol—Somnolence—Methotrexate—testicular cancer	0.000163	0.000291	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—testicular cancer	0.000162	0.000289	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—testicular cancer	0.000161	0.000288	CcSEcCtD
Tramadol—Hypotension—Epirubicin—testicular cancer	0.00016	0.000286	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—testicular cancer	0.00016	0.000285	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—testicular cancer	0.000159	0.000284	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000159	0.000283	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000158	0.000282	CcSEcCtD
Tramadol—Fatigue—Methotrexate—testicular cancer	0.000158	0.000282	CcSEcCtD
Tramadol—Infection—Doxorubicin—testicular cancer	0.000158	0.000281	CcSEcCtD
Tramadol—Pain—Methotrexate—testicular cancer	0.000157	0.00028	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000156	0.000279	CcSEcCtD
Tramadol—Shock—Doxorubicin—testicular cancer	0.000156	0.000279	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—testicular cancer	0.000155	0.000278	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—testicular cancer	0.000155	0.000277	CcSEcCtD
Tramadol—Insomnia—Epirubicin—testicular cancer	0.000155	0.000277	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—testicular cancer	0.000155	0.000276	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—testicular cancer	0.000154	0.000275	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—testicular cancer	0.000154	0.000275	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000153	0.000274	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—testicular cancer	0.000153	0.000273	CcSEcCtD
Tramadol—Somnolence—Epirubicin—testicular cancer	0.000152	0.000272	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—testicular cancer	0.000151	0.00027	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—testicular cancer	0.000151	0.000269	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—testicular cancer	0.000151	0.000269	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—testicular cancer	0.00015	0.000267	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—testicular cancer	0.000149	0.000266	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—testicular cancer	0.000148	0.000265	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000148	0.000264	CcSEcCtD
Tramadol—Fatigue—Epirubicin—testicular cancer	0.000148	0.000264	CcSEcCtD
Tramadol—Pain—Epirubicin—testicular cancer	0.000147	0.000262	CcSEcCtD
Tramadol—Constipation—Epirubicin—testicular cancer	0.000147	0.000262	CcSEcCtD
Tramadol—Urticaria—Methotrexate—testicular cancer	0.000145	0.00026	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—testicular cancer	0.000145	0.000258	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—testicular cancer	0.000145	0.000258	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000144	0.000258	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—testicular cancer	0.000143	0.000256	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—testicular cancer	0.000142	0.000254	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—testicular cancer	0.000141	0.000252	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—testicular cancer	0.000141	0.000252	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—testicular cancer	0.000141	0.000252	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—testicular cancer	0.00014	0.00025	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—testicular cancer	0.00014	0.000249	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—testicular cancer	0.000138	0.000246	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000137	0.000244	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—testicular cancer	0.000137	0.000244	CcSEcCtD
Tramadol—Urticaria—Epirubicin—testicular cancer	0.000136	0.000243	CcSEcCtD
Tramadol—Constipation—Doxorubicin—testicular cancer	0.000136	0.000242	CcSEcCtD
Tramadol—Pain—Doxorubicin—testicular cancer	0.000136	0.000242	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—testicular cancer	0.000135	0.000242	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—testicular cancer	0.000135	0.000242	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—testicular cancer	0.000135	0.000241	CcSEcCtD
Tramadol—Asthenia—Methotrexate—testicular cancer	0.000131	0.000235	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—testicular cancer	0.000131	0.000233	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00013	0.000232	CcSEcCtD
Tramadol—Pruritus—Methotrexate—testicular cancer	0.00013	0.000231	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—testicular cancer	0.000126	0.000225	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—testicular cancer	0.000126	0.000225	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—testicular cancer	0.000125	0.000224	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—testicular cancer	0.000125	0.000224	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—testicular cancer	0.000125	0.000224	CcSEcCtD
Tramadol—Asthenia—Epirubicin—testicular cancer	0.000123	0.00022	CcSEcCtD
Tramadol—Pruritus—Epirubicin—testicular cancer	0.000121	0.000216	CcSEcCtD
Tramadol—Dizziness—Methotrexate—testicular cancer	0.000121	0.000216	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—testicular cancer	0.000117	0.000209	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—testicular cancer	0.000117	0.000209	CcSEcCtD
Tramadol—Vomiting—Methotrexate—testicular cancer	0.000116	0.000208	CcSEcCtD
Tramadol—Rash—Methotrexate—testicular cancer	0.000115	0.000206	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—testicular cancer	0.000115	0.000206	CcSEcCtD
Tramadol—Headache—Methotrexate—testicular cancer	0.000115	0.000205	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—testicular cancer	0.000114	0.000203	CcSEcCtD
Tramadol—Dizziness—Epirubicin—testicular cancer	0.000113	0.000202	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—testicular cancer	0.000112	0.0002	CcSEcCtD
Tramadol—Vomiting—Epirubicin—testicular cancer	0.000109	0.000195	CcSEcCtD
Tramadol—Nausea—Methotrexate—testicular cancer	0.000109	0.000194	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—testicular cancer	0.000108	0.000194	CcSEcCtD
Tramadol—Rash—Epirubicin—testicular cancer	0.000108	0.000193	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—testicular cancer	0.000108	0.000193	CcSEcCtD
Tramadol—Headache—Epirubicin—testicular cancer	0.000107	0.000192	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—testicular cancer	0.000105	0.000187	CcSEcCtD
Tramadol—Nausea—Epirubicin—testicular cancer	0.000102	0.000182	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—testicular cancer	0.000101	0.00018	CcSEcCtD
Tramadol—Rash—Doxorubicin—testicular cancer	0.0001	0.000179	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—testicular cancer	9.99e-05	0.000178	CcSEcCtD
Tramadol—Headache—Doxorubicin—testicular cancer	9.93e-05	0.000177	CcSEcCtD
Tramadol—Nausea—Doxorubicin—testicular cancer	9.42e-05	0.000168	CcSEcCtD
